Lv63
2470 积分 2024-12-17 加入
Predicting the prognosis of epithelial ovarian cancer patients based on deep learning models
16天前
已完结
Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas
16天前
已完结
Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China
1个月前
已完结
Efficacy and Safety of Combination Therapy with PARP Inhibitors and Anti-Angiogenic Agents in Ovarian Cancer: A Systematic Review and Meta-Analysis
6个月前
已完结
A novel combination of niraparib and anlotinib in platinum-resistant ovarian cancer: Efficacy and safety results from the phase II, multi-center ANNIE study
7个月前
已完结
Effectiveness and safety of mono-anlotinib mono therapy or in combination with chemotherapy in platinum-resistant recurrent ovarian cancer: a single-center retrospective study
10个月前
已完结
Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review
10个月前
已完结
First evidence of olaparib maintenance therapy in patients with newly diagnosed homologous recombination deficient positive/BRCA wild-type ovarian cancer: real-world multicenter study
11个月前
已完结
皖公网安备34019202002308
